AMCP Applauds Congressional Passage of PIE Act to Help Safely Expedite Patient Access to Life-Saving Treatments

Representatives Brett Guthrie and Anna Eshoo led a bipartisan coalition in support of the PIE Act.

Alexandria, Va., Dec. 23, 2022 — AMCP (Academy of Managed Care Pharmacy) applauds Congress for passing the Pre-approval Information Exchange (PIE) Act of 2022. This bipartisan bill will enhance proactive information-sharing on new treatments between drug manufacturers and health plans. As a result, payers will be able to conduct their rigorous review of life-saving treatments concurrently with the Food and Drug Administration’s (FDA) review, a change that will help patients access treatments faster. The PIE Act provision was included in the Senate Amendment to H.R. 2617 – Consolidated Appropriations Act, 2023, which will now go to President Biden to be signed into law.

Representative Brett Guthrie (R-KY) has been steadfast in his leadership for the PIE Act, working with Democratic co-lead Representative Anna Eshoo (D-CA), both respective leaders of the Energy & Commerce Health Subcommittee. They, alongside original cosponsors Representatives Scott Peters (D-CA), Morgan Griffith (R-VA), Doris Matsui (D-CA), and Michael Burgess (R-TX), have been critical in advancing this important legislation.

“Health policy can often be complex, but the benefits of PIE are simple — it has the potential to save lives for generations to come,” said AMCP CEO Susan Cantrell, RPh, CAE. “By enhancing the way manufacturers share information with payers and plans, we will safely accelerate patient access to life-saving treatments. In light of the new and novel treatments currently in development for serious illnesses, we are confident PIE will have a positive impact on the lives of patients and their families.”

The PIE Act will clarify and enhance the type of information manufacturers can share with public and private plans alike. This will help Medicare and Medicaid develop more efficient coverage for the 100 million Americans who rely on those plans for their health care needs. Historically, Medicare and Medicaid have been limited in modifying coverage formularies during a plan year. PIE will help enhance the information flowing to plans and make the process more efficient, which will help level the playing field for patients covered in public plans considerably.

“PIE has been AMCP’s top priority for patient advocacy because of its immediate potential to help millions of individuals across the country,” continued Cantrell. “We are truly grateful to Representatives Brett Guthrie and Anna Eshoo for their bipartisan leadership on PIE to help millions of Americans receive the medical treatment they need in an efficient and timely way.”

Learn more on AMCP’s PIE resource page.   

About AMCP       

AMCP is the professional association leading the way to help patients get the medications they need at a cost they can afford. AMCP’s diverse membership of pharmacists, physicians, nurses, biopharmaceutical professionals, and other stakeholders leverage their specialized expertise in clinical evidence and economics to optimize medication benefit design and population health management and help patients access cost-effective and safe medications and other drug therapies. AMCP members improve the lives of nearly 300 million Americans served by private and public health plans, pharmacy benefit management firms, and emerging care models. Visit www.amcp.org.  

Press Contact:
Jim Cooney
Director, Integrated Marketing Communications
703.683.2652 | @email